GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

Wed, 23rd Dec 2020 14:50

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

San Leon Energy PLC - oil and gas production in Nigeria - Purchase of 98.0 million shares by Chief Executive Oisin Fanning, announced in May, is cancelled after Fanning is unable to arrange financing, company says, "owing to unforeseen complications" partly related to uncertainties in financial markets caused by Covid-19. As a result, the shares, representing over 20% of the company, remain with funds managed by Toscafund Asset Management LLP, which now have 330.6 million shares, a 73.5% stake. Fanning has 9.5 million shares, a 2.1% holding. "Toscafund has further reaffirmed its support of the board of San Leon and the company's strategy to invest in strategic assets whilst maintaining a financially strong position," San Leon says. Purchase had been at 21 pence a share, making it worth GBP20.6 million. San Leon shares were trading at 22.80p on Wednesday in London.

----------

City of London Group PLC - investment company - Jason Oakley, CEO of subsidiary Recognise Bank Ltd, buys 50,000 shares at 85p, worth GBP42,500, on Tuesday.

----------

BBGI Global Infrastructure SA - infrastructure investor formerly known as BBGI SICAV - Chief Financial Officer Michael Denny buys 20,000 shares at GBP1.68, worth GBP33,600, on Wednesday.

----------

Origin Enterprises PLC - Dublin-based agri-services - Non-Executive Director Helen Kirkpatrick buys 5,000 shares at EUR3.43, worth EUR17,150, on Wednesday. The purchase is her only holding, having joined the board in October.

----------

Redx Pharma PLC - Macclesfield, England-based drug development in cancer and fibrosis - CEO Lisa Anson buys 39,998 shares at 50p, worth GBP19,999, on Tuesday. Now has 129,284 shares.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 May 2015 08:15

Redx Pharma Reaches Pre-Clinical Stage With Oncology Compound

Read more
27 Mar 2015 10:35

REPEAT: Redx Pharma Shares Tick Up After AIM IPO As Sanne Prices Its Offering (ALLIPO)

Read more
27 Mar 2015 10:26

Redx Pharma Shares Tick Up After AIM IPO As Sanne Prices Its Offering

Read more
27 Mar 2015 09:43

Redx Pharma enjoys successful AIM debut

Shares in pharmaceutical development company Redx Pharma traded at a small premium upon the company's debut on the London Stock Exchange. The Liverpool-based group began trading on AIM on Friday, having raised £15m in gross proceeds after placing 17.6m shares at 85p each. The company, which has nom

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.